Chen Huitong, Guan Qian, Guo Huiqin, Miao Lei, Zhuo Zhenjian
Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
School of Medicine, South China University of Technology, Guangzhou, China.
Front Oncol. 2021 Jul 21;11:690641. doi: 10.3389/fonc.2021.690641. eCollection 2021.
Hepatoblastoma is the most common malignant liver cancer in childhood. The etiology of hepatoblastoma remains obscure. Hepatoblastoma is closely related to genetic syndromes, hinting that hepatoblastoma is a genetic predisposition disease. However, no precise exposures or genetic events are reported to hepatoblastoma occurrence. During the past decade, significant advances have been made in the understanding of etiology leading to hepatoblastoma, and several important genetic events that appear to be important for the development and progression of this tumor have been identified. Advances in our understanding of the genetic changes that underlie hepatoblastoma may translate into better patient outcomes. Single nucleotide polymorphisms (SNPs) have been generally applied in the research of etiology's exploration, disease treatment, and prognosis assessment. Here, we reviewed and discussed the molecular epidemiology, especially SNPs progresses in hepatoblastoma, to provide references for future studies and promote the study of hepatoblastoma's etiology.
肝母细胞瘤是儿童期最常见的恶性肝癌。肝母细胞瘤的病因仍不清楚。肝母细胞瘤与遗传综合征密切相关,这提示肝母细胞瘤是一种具有遗传易感性的疾病。然而,尚未有关于肝母细胞瘤发生的确切暴露因素或基因事件的报道。在过去十年中,我们对导致肝母细胞瘤的病因的认识取得了重大进展,并且已经确定了一些对该肿瘤的发生和发展似乎很重要的重要基因事件。我们对肝母细胞瘤潜在的基因变化的认识进展可能会转化为更好的患者预后。单核苷酸多态性(SNP)已普遍应用于病因探索、疾病治疗和预后评估的研究中。在此,我们回顾并讨论了肝母细胞瘤的分子流行病学,特别是SNP方面的进展,为未来的研究提供参考,并促进肝母细胞瘤病因学的研究。